HIMS Shares Jump 7.06% on $1.36 Billion Trading Volume Surge to 48th in Market Activity

Hims & Hers Health (HIMS) surged 7.06% on Sept. 3, 2025, with a trading volume of $1.36 billion—a 127.58% increase from the prior day—ranking it 48th in market activity. The stock’s sharp rise followed a strategic update highlighting expanded telehealth services and a partnership with a major pharmacy chain to streamline prescription fulfillment. Analysts noted the move could enhance customer retention and reduce operational costs, though some cautioned about regulatory scrutiny in the healthcare sector.

Recent filings revealed a 20% reduction in third-quarter revenue guidance due to slower-than-expected adoption of its new skincare line. However, the company emphasized that the telehealth segment grew by 35% year-to-date, driven by seasonal demand and improved user engagement metrics. Short-sellers trimmed positions by 15% in the past week, suggesting a potential shift in market sentiment despite near-term revenue concerns.

Technical indicators show HIMS has broken above a key resistance level at $12.50, with the Relative Strength Index (RSI) stabilizing in overbought territory. A review of historical performance over the past 60 days indicates that 70% of days with trading volumes exceeding $1 billion were followed by a 2%-4% upward move in the subsequent week, though this pattern has weakened in recent months due to increased market volatility.